Jump to content

Encore: Putting Zytiga (abiraterone) on the Australian PBS: decision clarified


Recommended Posts

Jim Marshall (not a doctor) said ...

The PBAC is a committee that recommends which drugs go on the PBS (Pharmaceutical Benefits Scheme) to be free, or nearly free, to people in Australia who need them.

The PBAC at its November 2012 meeting considered whether Zytiga (abiraterone) should be put on the PBS to be free, or nearly free, to men who have failed chemotherapy with docetaxel (Taxotere).

The PBAC has approved this happening, subject to certain conditions.

That is sometimes NOT the end of the process. Companies can withdraw their request for listing if the conditions set are not acceptable to them.

In the past, Zytiga (abiraterone) has been approved by the PBAC under certain conditions more than once, but the company has withdrawn its application on each occasion because it found the conditions unacceptable.

So, we must wait to hear if the company (Janssen-Cilag Pty Ltd) is satisfied with the conditions before we celebrate the listing of Zytiga on the PBS.

... end Jim

Link to comment
Share on other sites


This topic is now archived and is closed to further replies.

  • Create New...